The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Evidence-Based Platelet Transfusion Guidelines
Open accessAbstract
Transfused platelets (plts) are either pooled random-donor platelet (plt) concentrates or single-donor apheresis plts. When stored for 5 days, all of these products are equally efficacious. A 10,000/μL prophylactic plt transfusion trigger has been documented to be both hemostatically efficacious and cost effective in reducing plt transfusion requirements. The optimal plt dose/transfusion is being evaluated in an ongoing clinical trial. Therapeutic plt transfusions to control or prevent bleeding with trauma or surgical procedures require higher transfusion triggers of 100,000/μL for neurosurgical procedures and between 50,000/μL and 100,000/μL for other invasive procedures or trauma. Leukoreduction has been documented to reduce plt alloimmunization rates, cytomegalovirus (CMV) transmission by transfusion, and febrile transfusion reactions. Whether it reduces immunomodulatory effects of transfusion (i.e., decreases infection rates and cancer recurrence) is still controversial, as is universal leukoreduction. Poor responses to plt transfusions are often multifactorial. For alloimmune plt refractoriness, HLA matching, cross-matching, and identification of the specificity of the patient’s antibodies with avoidance of mismatched donor antigens are all equally effective in identifying compatible plts for transfusion. Other causes of poor plt responses are splenomegaly, ABO mismatching, females with 2 or more pregnancies and males, use of heparin or amphotericin, bleeding, fever, graft-vs-host disease (GVHD), and vaso-occlusive disease (VOD).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
Vamvakas, E. C., & Blajchman, M. A. (2001) · Blood · doi:10.1182/blood.v97.5.1180 · Cited by 423 · cited 2×
“ABO Mismatched 13 2 (15%) 4 (31%) 9 (4-30) 9 (69%) 7 (54%) 5 (38%) 4 (31%)”
Cited by
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
Stanworth, S. J., Estcourt, L. J., Powter, G., Kahan, B. C., Dyer, C., Choo, L., Bakrania, L., Llewelyn, C., Littlewood, T., Soutar, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212772 · Cited by 472
Traumatic Intracranial Hypertension
Stocchetti, N., & Maas, A. I. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1208708 · Cited by 394
Bleeding and Coagulopathies in Critical Care
Hunt, B. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1208626 · Cited by 324
Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
Afdhal, N. H., Giannini, E. G., Tayyab, G., Mohsin, A., Lee, J.-W., Andriulli, A., Jeffers, L., McHutchison, J., Chen, P.-J., Han, K.-H., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110709 · Cited by 321
Metadata
- Authors
- Slichter, S. J.
- Venue
- Hematology
- Publisher
- American Society of Hematology
- Published
- 2007-01-01
- Volume
- 2007
- Issue
- 1
- Pages
- 172-178
- ISSN
- 1520-4383 (ISSN-L)
- 1520-4391
- OpenAlex
- W2166770716
- Cited by
- 248
- References
- 1
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence-Based Platelet Transfusion Guidelines. https://app.cochat.ai/papers/10.1182/asheducation-2007.1.172
- The paper
- Slichter, S. J. (2007). Evidence-Based Platelet Transfusion Guidelines. Hematology. https://doi.org/10.1182/asheducation-2007.1.172
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.